Approval · Notice of Compliance 22719 · 2019
ELIDEL: Notice of Compliance 22719
Issued September 26, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22719
- Date
- September 26, 2019
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To expand the indication to include children, ages 3 months to 2 years. to delete the boxed warning regarding long-term use from the pm. update pm to 2016 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELIDEL | Not yet assigned | — |
Medicinal ingredients
- PIMECROLIMUS 1 PER